- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
China National Accord Medicines Corp Ltd (000028)
China National Accord Medicines Corp Ltd stock price live, this page displays SZ 000028 stock exchange data. View the 000028 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the China National Accord Medicines Corp Ltd real time stock price chart below.
What Is the China National Accord Medicines Corp Ltd Stock Price Today?
The China National Accord Medicines Corp Ltd stock price today is 25.82.
What Is the Stock Symbol for China National Accord Medicines Corp Ltd?
The stock symbol for China National Accord Medicines Corp Ltd is ""000028.""
What Stock Exchange Does China National Accord Medicines Corp Ltd Trade On?
China National Accord Medicines Corp Ltd is listed and trades on the Shenzhen stock exchange.
Is China National Accord Medicines Corp Ltd a Good Stock to Buy?
Determining whether China National Accord Medicines Corp Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 000028 quote. (ISIN: CNE0000009N6)
What Is the China National Accord Medicines Corp Ltd Stock Price Today?
The China National Accord Medicines Corp Ltd stock price today is 25.82.
What Is the Stock Symbol for China National Accord Medicines Corp Ltd?
The stock symbol for China National Accord Medicines Corp Ltd is ""000028.""
What Stock Exchange Does China National Accord Medicines Corp Ltd Trade On?
China National Accord Medicines Corp Ltd is listed and trades on the Shenzhen stock exchange.
Is China National Accord Medicines Corp Ltd a Good Stock to Buy?
Determining whether China National Accord Medicines Corp Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 000028 quote. (ISIN: CNE0000009N6)
25.82
+0.34(+1.33%)
Closed·
Fair Value
An estimate of a National Accord A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.49
25.85
52 wk Range
23.68
34.79
000028 Scorecard
Full Analysis
High shareholder yield
000028 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a National Accord A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.4925.85
52 wk Range
23.6834.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.44%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.44%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
000028 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a National Accord A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
26.45
Upside
+2.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
China National Accord Medicines Corp Ltd Company Profile
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. It offers drugs, medical equipment, cargo transportation, warehousing, loading and unloading, glass instruments, cosmetics, sales of daily necessities, other business services, and other professional consulting services; agent services; and house leasing services. The company is also involved in the import and export of proprietary Chinese medicines, chemical preparations, antibiotics, biochemical drugs, biological preparations, diagnostic drugs, therapeutic and diagnostic biological products, packaged foods, chemical products, house supplies, and self-operated technologies. In addition, it engages in the retail and distribution of medical devices, as well as wholesale and retail of health supplies, etc. The company was formerly known as Shenzhen Health Mineral Water Corp., Ltd. The company was incorporated in 1993 and is headquartered in Shenzhen, China. China National Accord Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co., Ltd.
Compare 000028 to Peers and Sector
Metrics to compare | 000028 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000028PeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.0x | 25.5x | −0.5x | |
PEG Ratio | −0.36 | −0.44 | 0.00 | |
Price/Book | 0.7x | 1.0x | 2.6x | |
Price / LTM Sales | 0.2x | 0.4x | 3.2x | |
Upside (Analyst Target) | 10.9% | 14.2% | 41.9% | |
Fair Value Upside | Unlock | 14.5% | 4.3% | Unlock |
Analyst Ratings
3 Buy
1 Hold
2 Sell
Ratings:
6 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 26.45
(+2.45% Upside)
Earnings
Latest Release
Apr 25, 2025
EPS / Forecast
0.59 / 0.61
Revenue / Forecast
18.29B / 20.53B
FAQ
What Stock Exchange Does National Accord A Trade On?
National Accord A is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for National Accord A?
The stock symbol for National Accord A is "000028."
What Is the National Accord A Market Cap?
As of today, National Accord A market cap is 14.37B.
What Is National Accord A's Earnings Per Share (TTM)?
The National Accord A EPS (TTM) is 1.04.
When Is the Next National Accord A Earnings Date?
National Accord A will release its next earnings report on 26 Aug 2025.
From a Technical Analysis Perspective, Is 000028 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has National Accord A Stock Split?
National Accord A has split 5 times.
How Many Employees Does National Accord A Have?
National Accord A has 39449 employees.
What is the current trading status of National Accord A (000028)?
As of 24 Jul 2025, National Accord A (000028) is trading at a price of 25.82, with a previous close of 25.48. The stock has fluctuated within a day range of 25.49 to 25.85, while its 52-week range spans from 23.68 to 34.79.
What Is National Accord A (000028) Price Target According to Analysts?
The average 12-month price target for National Accord A is CNY26.452, with a high estimate of CNY32.13 and a low estimate of CNY19.5. 3 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +2.45% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.